A detailed history of Goldman Sachs Group Inc transactions in Eyenovia, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 362,183 shares of EYEN stock, worth $181,091. This represents 0.0% of its overall portfolio holdings.

Number of Shares
362,183
Previous 17,763 1938.97%
Holding current value
$181,091
Previous $17,000 1152.94%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$0.52 - $1.06 $179,098 - $365,085
344,420 Added 1938.97%
362,183 $213,000
Q1 2024

May 15, 2024

SELL
$0.99 - $2.37 $4,135 - $9,899
-4,177 Reduced 19.04%
17,763 $17,000
Q4 2023

Feb 13, 2024

SELL
$1.08 - $2.08 $366,696 - $706,230
-339,534 Reduced 93.93%
21,940 $45,000
Q3 2023

May 14, 2024

BUY
$1.57 - $2.54 $533,068 - $862,416
339,534 Added 1547.56%
361,474 $600,000
Q3 2023

Nov 14, 2023

BUY
$1.57 - $2.54 $549,025 - $888,232
349,698 Added 2969.58%
361,474 $600,000
Q2 2023

May 14, 2024

SELL
$2.21 - $5.75 $22,462 - $58,443
-10,164 Reduced 46.33%
11,776 $27,000
Q2 2023

Aug 14, 2023

BUY
$2.21 - $5.75 $26,024 - $67,712
11,776 New
11,776 $27,000

Others Institutions Holding EYEN

About EYENOVIA, INC.


  • Ticker EYEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,212,900
  • Market Cap $17.1M
  • Description
  • Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the develop...
More about EYEN
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.